The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
This is Custom Cart, it looks to be just a very basic front end with no fulfilment, doesn't look to have changed much since the 90's either ..
https://www.customcart.com/
It was fist highlighted here around Nov/Dec time, something had changed in the way data is being collected by web sites for forecasting/analytical purposes.
For example two of the major aggregator web sites no longer have THG Ingenuity listed, while others have little to no updates, of the new entries some are incorrect with THG own brands appearing on competitor sites.
Homebase are listed as moving onto Custom Cart in March of this year, to my knowledge Custom Cart do not operate in the UK, also when looking at DNS records it still lists 'THG Ingenuity'
https://who.is/dns/homebase.co.uk (click DNS tab)
Any techies out there who may know of changes, perhaps EU driven GDPR type initiatives ?
The other thought is maybe THG have pulled their data from being tracked.
Market is super fickle, the moment THG pay down debt rates will go down and the market will start criticising companies for holding cash, always happens.
The absolute worst thing any listed company can do is deviate from their strategy by pandering to analysts who lets face it, have no idea how to run a business.
..from a company that HCM is currently partners with, who have expressed a strong commitment to China, building out new offices and R & D facilities, not to mention oncology portfolio.
Two deals in one month..
The deal is AstraZeneca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio.
The drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company’s closing price on Monday.
https://www.cnbc.com/2024/03/19/astrazeneca-bets-on-new-cancer-treatments-with-2-billion-fusion-pharma-purchase.html
List of funds, copy and paste into Excel adding up 'shares' column, this is only US funds so figure could be higher with EU/world trackers.
https://fintel.io/so/gb/thg
iShares $100b world wide fund
"Dwight, Fed's inflation data has come in hot, what do want to do ?"
"Screw, that, Matt's just put up a LinkedIn post "
Eric Wintemute, Chairman and CEO of American Vanguard, stated: ″We rebounded sharply in Q4 after having weathered the effect of global destocking within the distribution channel, the oversupply of Chinese generic products into multiple regions, and the unavailability of our most profitable products due to supply chain issues.
Increased demand during Q4 provided evidence that destocking activity continues to subside and that, even while showing greater discipline, procurement within the distribution channel is following more normal patterns.
https://news.agropages.com/News/NewsDetail---49527.htm
Re-elections are normally every two years for senior management, unlikely to be the same as last year unless special resolutions tabled.
The drop has nothing to do with a LinkedIn post, hot inflation data pushed back interest rates drops last wk, trackers will adjust accordingly.
Checkout the links posted previously on tracker changes, 5% of the stock is help with these funds changing constantly up/down.
Another step towards wider adoption for biologicals , PHC target markets to - crops such as corn, soybeans, cotton, sugar cane, coffee, rice and oranges.
https://news.agropages.com/News/NewsDetail---49526.htm
These JV's can pop up at anytime, Ulta is a good example - released their results this evening:
"We have evaluated various operating models and partners, and geographies, and we are excited to announce the formation of a joint venture with Axo, a highly experienced operator of global brands, to launch and operate Ulta Beauty in Mexico in 2025.”
Lets say Ulta wanted to move into Europe next.
Ulta results here, growth subdued but still moving forward:
https://www.businesswire.com/news/home/20240314247150/en/Ulta-Beauty-Announces-Fourth-Quarter-Fiscal-2023-Results
OSG, one possible reason is they can have up to three separate partnerships if needed, keeps everything tidy accounting wise - may even be a requirement for Premium listing, not sure.
Without looking at my notes, the term 'optionality' springs to mind, perhaps this was said on one of the analyst calls.
Jefferies have a long history with THG management, would certainly take onboard their comments with more weight.
https://www.londonstockexchange.com/news-article/THG/response-to-press-speculation/15918839
100% agree, only word missing is 'symbiotic'
“Although a divisional IPO has been mooted, we see a strategic partnership as potentially more likely, opening up new growth and synergy options,” Jefferies said in a note on Thursday.
Mentioned Sir Tom Hunter yesterday in response to another question.
This interview from a couple of years ago is a great humorous insight into how THG came about, highly recommend.
https://www.youtube.com/watch?v=pMjDjkQsAYM
Its relative, consider that a large % of the share holder base have been invested for 14 years or more.
That includes of course Matt/directors but also Balderton and several others, even Sofina a relative 'newbie' has 8 years under their belt.
'Sofina acquired an initial stake in the company in 2016 in order to finance the expansion of the group. Throughout 2017, 2018 and 2019, Sofina purchased additional shares through both primary and secondary transactions in order to support the group’s fast growth. Finally, in 2020, Sofina supported the company’s IPO and took the opportunity to further strengthen its capital base.'
FMC Corporation expands biologicals crop protection platform in Canada
https://finance.yahoo.com/news/fmc-corporation-expands-biologicals-crop-113000728.html
Sir Tom hunter increased through his investment vehicle, West Coast Capital.
https://www.westcoastcapital.co.uk/portfolio_works/the-hut-group/
Indeed, I would have to look back at my notes but from memory Mark's names rings a bell, these were the declarations from that period.
Long positions, previous notified holdings in (brackets)
Ophorst Van Marwijk Kooy Asset Management (1.94%) ……………………… 1.93%
Balderton Capital (UK) LLP ……………………… 7.46%
BlackRock, Inc (1.23%) ……………………… 1.22%
The Vanguard Group, Inc. (2.62%) ……………………… 2.63%
Sofina Capital S.A ……………………… 8.89%
Kelso ……………………… 0.60%
Brian George Kennedy ……………………… 2.86%
Norges Bank (1.73%) ……………………… 1.81%
West Coast Capital (1.41%) ……………………… 2.03%
Qatar Investment Authority ……………………… 7.32%
Matthew Moulding/Close relative of Matthew Moulding ……………………… 15.80%
THG Employee Benefit Trust ……………………… 5.90%
Tim Bunting (Balderton Capital (UK) LLP) ……………………… 1.31%
Mark Evans (ex- General Partner at Balderton) ……………………… 2.71%
Sir Terence Patrick Leahy ……………………… 1.24%
HARBROOK LIMITED ……………………… 1.97%
Total ……………………… 65.68%
Notifications deemed trading or prop accounts omitted
Errors and omissions accepted